Welcome to Flash Glucose Monitoring with
FreeStyle Libre system.
The days of routine glucose testing with lancets, test strips and blood are over.
The FreeStyle Libre system liberates you from the hassles of routine finger prick testing. Just scan the reader over the sensor worn on the back of your upper arm to check your glucose levels.
The FreeStyle Libre Flash Glucose Monitoring System
- Convenient
The sensor automatically measures and continuously stores glucose readings day and night.
- User friendly
With every scan you get your current glucose reading, the last 8 hours of glucose data and a trend arrow that shows you where your glucose is heading.
- Discreet
Glucose readings with a painless one-second scan even through your clothing2.
- Easy
The FreeStyle Libre system is designed to be water-resistant3 and worn while bathing, showering, swimming and exercising.
As easy as 1,2,3
Apply
Apply the sensor to the back of your upper arm with the applicator.
.png){kind=icon}
Scan
A painless one-second scan is all you need to see your glucose readings.
.png){kind=icon}
Read out
See your current glucose reading, eight hours of data, and a trend arrow that shows you where your glucose is heading.
Data based on the number of users worldwide for the FreeStyle Libre system compared to the number of users for other leading personal use sensor based glucose monitoring systems.
1. Data on file: Abbott Diabetes Care Inc.
2. The FreeStyle Libre reader can capture data from within 1cm to 4cm of the sensor, even through clothing.
3. The sensor is water resistant in up to 1 meter (3feet). Do not immense longer than 30 minutes.
References:
^. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254-2263.
$. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1): 55-73.
Images are for illustration purpose only.
ADC-28471 v1.0 10/20